By continuing to use our site, you consent to the processing of cookies, user data (location information, type and version of the OS, the type and version of the browser, the type of device and the resolution of its screen, the source of where the user came from, from which site or for what advertisement, language OS and Browser, which pages are opened and to which buttons the user presses, ip-address) for the purpose of site functioning, retargeting and statistical surveys and reviews. If you do not want your data to be processed, please leave the site.
The Voice of People With Breast Cancer
Education
Publications
& Resources
Advancements in Care Through Precision Oncology: November 11, 2026
After watching, please take a few minutes to complete our post-session survey and share your feedback with us.
About: No two breast cancers are exactly alike, and treatment is becoming more personalized than ever before. Join us as we explore how precision oncology is changing the way breast cancer is diagnosed and treated, including the latest advances in genetic testing, biomarkers, and targeted therapies, and what these developments may mean for you. n this webinar, our expert speaker, Katherina Baranova, discussed:
- What precision oncology is and why it matters
- Advances in genomic and molecular testing
- Emerging targeted therapies and personalized treatment approaches
- Advances in molecular and biomarker testing
- Recent clinical trial findings and emerging research
- Access to precision medicine for people with breast cancer
Expert Speaker:
Katherina Baranova is a graduate of Schulich School of Medicine for medical school followed by Diagnostic and Molecular Pathology residency. She is currently in the second year of the European Masters of Molecular Pathology program, and a practicing locum pathologist with experience in breast pathology at Cambridge Memorial Hospital, Ontario. Dr. Baranova is a published scientific author on topics related to breast cancer chemotherapy resistance, molecular signatures in rare central nervous system tumours, and genetic syndromes in renal tumours.
Resources:
- Review the slides for this webinar
- Access CBCN's Precision Oncology Toolkit
- Learn more about breast cancer subtypes
- Watch our previous workshop on understanding your pathology report
- Interested in getting a second opinion? Learn how.
- Learn more about the changes in categorizing HER2 status
SHARE
Our Stories
Events
Receive updates by email Subscribe Now
About CBCN
CBCN strives to voice the views and concerns of breast cancer patients through education, advocacy activities, and the promotion of information sharing.
Canadian Breast Cancer Network
Mailing Address: M013 - 1367 Clyde Ave. Ottawa, ON K2G 3H7
Tel: 613-230-3044
Toll-free: 1-800-685-8820
Email Us
